1,5-取代 1,2,4-三唑类化合物的合成及作为顺式受限的康普瑞汀类似物的抗肿瘤活性。
Synthesis and antitumor activity of 1,5-disubstituted 1,2,4-triazoles as cis-restricted combretastatin analogues.
机构信息
Dipartimento di Scienze Farmaceutiche, Università di Ferrara, Ferrara, Italy.
出版信息
J Med Chem. 2010 May 27;53(10):4248-58. doi: 10.1021/jm100245q.
Abstract
A series of 1-aryl-5-(3',4',5'-trimethoxyphenyl) derivatives and their related 1-(3',4',5'-trimethoxyphenyl)-5-aryl-1,2,4-triazoles, designed as cis-restricted combretastatin analogues, were synthesized and evaluated for antiproliferative activity, inhibitory effects on tubulin polymerization, cell cycle effects, and apoptosis induction. Their activity was greater than, or comparable with, that of the reference compound CA-4. Flow cytometry studies showed that HeLa and Jurkat cells treated with the most active compounds 4l and 4o were arrested in the G2/M phase of the cell cycle in a concentration dependent manner. This effect was accompanied by apoptosis of the cells, mitochondrial depolarization, generation of reactive oxygen species, activation of caspase-3, and PARP cleavage. Compound 4l was also shown to have potential antivascular activity, since it induced endothelial cell shape change in vitro and disrupted the sprouting of endothelial cells in the chick aortic ring assay.
摘要
一系列 1-芳基-5-(3',4',5'-三甲氧基苯基)衍生物及其相关的 1-(3',4',5'-三甲氧基苯基)-5-芳基-1,2,4-三唑，被设计为顺式限制型康普瑞汀类似物，被合成并评估了其抗增殖活性、对微管聚合的抑制作用、细胞周期效应和细胞凋亡诱导作用。它们的活性大于或与参考化合物 CA-4 相当。流式细胞术研究表明，用最活性化合物 4l 和 4o 处理的 HeLa 和 Jurkat 细胞在细胞周期的 G2/M 期被浓度依赖性地阻滞。这种作用伴随着细胞凋亡、线粒体去极化、活性氧的产生、caspase-3 的激活和 PARP 切割。化合物 4l 还显示出潜在的抗血管生成活性，因为它在体外诱导内皮细胞形态改变，并破坏鸡主动脉环试验中内皮细胞的发芽。
相似文献
1
Synthesis and antitumor activity of 1,5-disubstituted 1,2,4-triazoles as cis-restricted combretastatin analogues.1,5-取代 1,2,4-三唑类化合物的合成及作为顺式受限的康普瑞汀类似物的抗肿瘤活性。
J Med Chem. 2010 May 27;53(10):4248-58. doi: 10.1021/jm100245q.
2
Synthesis, antiproliferative, anti-tubulin activity, and docking study of new 1,2,4-triazoles as potential combretastatin analogues.新型1,2,4-三唑作为潜在康普瑞他汀类似物的合成、抗增殖、抗微管蛋白活性及对接研究
Eur J Med Chem. 2017 Dec 1;141:293-305. doi: 10.1016/j.ejmech.2017.09.063. Epub 2017 Sep 28.
3
Synthesis and biological evaluation of cis-restricted triazole/tetrazole mimics of combretastatin-benzothiazole hybrids as tubulin polymerization inhibitors and apoptosis inducers.作为微管蛋白聚合抑制剂和凋亡诱导剂的柯里拉京-苯并噻唑杂合物的顺式受限三唑/四唑模拟物的合成及生物学评价
Bioorg Med Chem. 2017 Feb 1;25(3):977-999. doi: 10.1016/j.bmc.2016.12.010. Epub 2016 Dec 9.
4
Synthesis and biological evaluation of 1,2,3-triazole linked aminocombretastatin conjugates as mitochondrial mediated apoptosis inducers.1,2,3-三唑连接的氨基秋水仙碱缀合物作为线粒体介导的凋亡诱导剂的合成及生物学评价
Bioorg Med Chem. 2014 Oct 1;22(19):5155-67. doi: 10.1016/j.bmc.2014.08.008. Epub 2014 Aug 19.
5
Synthesis and antiproliferative activity of conformationally restricted 1,2,3-triazole analogues of combretastatins in the sea urchin embryo model and against human cancer cell lines.在海胆胚胎模型及针对人类癌细胞系中，柯里他汀构象受限的1,2,3-三唑类似物的合成及其抗增殖活性
Bioorg Med Chem. 2014 Jan 15;22(2):738-55. doi: 10.1016/j.bmc.2013.12.015. Epub 2013 Dec 12.
6
Discovery and optimization of a series of 2-aryl-4-amino-5-(3',4',5'-trimethoxybenzoyl)thiazoles as novel anticancer agents.发现并优化一系列 2-芳基-4-氨基-5-(3',4',5'-三甲氧基苯甲酰基)噻唑类化合物作为新型抗癌剂。
J Med Chem. 2012 Jun 14;55(11):5433-45. doi: 10.1021/jm300388h. Epub 2012 May 21.
7
Design, synthesis and biological evaluation of novel vicinal diaryl-substituted 1H-Pyrazole analogues of combretastatin A-4 as highly potent tubulin polymerization inhibitors.新型邻二芳基取代 1H-吡唑类似物的设计、合成及生物评价作为高活性的微管蛋白聚合抑制剂。
Eur J Med Chem. 2019 Nov 1;181:111577. doi: 10.1016/j.ejmech.2019.111577. Epub 2019 Aug 1.
8
Pyrrolotetrazinones deazaanalogues of temozolomide induce apoptosis in Jurkat cell line: involvement of tubulin polymerization inhibition.替莫唑胺的吡咯并四嗪酮脱氮类似物诱导Jurkat细胞系凋亡：微管蛋白聚合抑制的参与
Cancer Chemother Pharmacol. 2009 Nov;64(6):1235-51. doi: 10.1007/s00280-009-0994-9. Epub 2009 Apr 11.
9
Synthesis, antimitotic and antivascular activity of 1-(3',4',5'-trimethoxybenzoyl)-3-arylamino-5-amino-1,2,4-triazoles.1-(3',4',5'-三甲氧基苯甲酰基)-3-芳基氨基-5-氨基-1,2,4-三唑的合成、抗有丝分裂和抗血管活性
J Med Chem. 2014 Aug 14;57(15):6795-808. doi: 10.1021/jm5008193. Epub 2014 Jul 28.
10
Discovery and hit to lead optimization of novel combretastatin A-4 analogues: dependence of C-linker length and hybridization.新型康普瑞汀 A-4 类似物的发现和先导优化：C 键连接长度和杂交的依赖性。
Anticancer Agents Med Chem. 2013 Dec;13(10):1614-35. doi: 10.2174/187152061310131206162302.
引用本文的文献
1
Development of di-arylated 1,2,4-triazole-based derivatives as therapeutic agents against breast cancer: synthesis and biological evaluation.基于二芳基化1,2,4-三唑的衍生物作为抗乳腺癌治疗药物的开发：合成与生物学评价
RSC Med Chem. 2024 Jul 22;15(9):3097-3113. doi: 10.1039/d4md00285g. eCollection 2024 Sep 19.
2
A Review on the Mechanism and Structure-activity Relationship of Resveratrol Heteroaryl Analogues.白藜芦醇杂芳基类似物的作用机制和构效关系研究进展
Comb Chem High Throughput Screen. 2024;27(7):947-958. doi: 10.2174/1386207326666230713125512.
3
Metal catalyzed C-H functionalization on triazole rings.金属催化的三唑环上的C-H官能团化反应。
RSC Adv. 2022 Sep 28;12(42):27534-27545. doi: 10.1039/d2ra05697f. eCollection 2022 Sep 22.
4
An in vivo evaluation of anti-inflammatory, analgesic and anti-pyretic activities of newly synthesized 1, 2, 4 Triazole derivatives.一种新合成的 1,2,4-三唑衍生物的抗炎、镇痛和解热活性的体内评价。
BMC Complement Med Ther. 2021 Dec 31;21(1):304. doi: 10.1186/s12906-021-03485-x.
5
New Multi-Targeted Antiproliferative Agents: Design and Synthesis of IC261-Based Oxindoles as Potential Tubulin, CK1 and EGFR Inhibitors.新型多靶点抗增殖剂：基于IC261的吲哚酮类化合物作为潜在微管蛋白、细胞周期蛋白依赖性激酶1和表皮生长因子受体抑制剂的设计与合成
Pharmaceuticals (Basel). 2021 Oct 30;14(11):1114. doi: 10.3390/ph14111114.
6
Discovery of Novel Diarylamide -Containing Heterocyclic Derivatives as New Tubulin Polymerization Inhibitors with Anti-Cancer Activity.新型含二芳基酰胺杂环衍生物作为具有抗癌活性的新型微管蛋白聚合抑制剂的发现。
Molecules. 2021 Jul 2;26(13):4047. doi: 10.3390/molecules26134047.
7
Application of triazoles as bioisosteres and linkers in the development of microtubule targeting agents.三唑类作为生物电子等排体和连接子在微管靶向剂研发中的应用。
RSC Med Chem. 2020 Jan 29;11(3):327-348. doi: 10.1039/c9md00458k. eCollection 2020 Mar 1.
8
An insight on medicinal attributes of 1,2,4-triazoles.对 1,2,4-三唑药用属性的深入了解。
Eur J Med Chem. 2020 Nov 1;205:112652. doi: 10.1016/j.ejmech.2020.112652. Epub 2020 Jul 27.
9
Synthesis, Characterization and Photodynamic Activity against Bladder Cancer Cells of Novel Triazole-Porphyrin Derivatives.新型三唑-卟啉衍生物的合成、表征及对膀胱癌细胞的光动力活性。
Molecules. 2020 Mar 31;25(7):1607. doi: 10.3390/molecules25071607.
10
Germacrone cooperates with dexmedetomidine to alleviate high-fat diet-induced type 2 diabetes mellitus via upregulating AMPKα1 expression.吉马酮与右美托咪定协同作用，通过上调AMPKα1表达减轻高脂饮食诱导的2型糖尿病。
Exp Ther Med. 2019 Nov;18(5):3514-3524. doi: 10.3892/etm.2019.7990. Epub 2019 Sep 9.
本文引用的文献
1
Design, synthesis and structure-activity relationship of 2-(3',4',5'-trimethoxybenzoyl)-benzo[b]furan derivatives as a novel class of inhibitors of tubulin polymerization.设计、合成及 2-(3',4',5'-三甲氧基苯甲酰基)-苯并[b]呋喃衍生物作为新型微管蛋白聚合抑制剂的构效关系研究。
Bioorg Med Chem. 2009 Oct 1;17(19):6862-71. doi: 10.1016/j.bmc.2009.08.027. Epub 2009 Aug 20.
2
1,5-Disubstituted 1,2,3-triazoles as cis-restricted analogues of combretastatin A-4: Synthesis, molecular modeling and evaluation as cytotoxic agents and inhibitors of tubulin.1,5-二取代-1,2,3-三唑作为康普瑞他汀A-4的顺式受限类似物：合成、分子模拟以及作为细胞毒性剂和微管蛋白抑制剂的评价
Bioorg Med Chem. 2008 May 1;16(9):4829-38. doi: 10.1016/j.bmc.2008.03.049. Epub 2008 Mar 23.
3
Combretastatin a-4 analogs as anticancer agents.癌栓素a - 4类似物作为抗癌剂。
Mini Rev Med Chem. 2007 Dec;7(12):1186-205. doi: 10.2174/138955707782795647.
4
Central role of mitochondria and p53 in PUVA-induced apoptosis in human keratinocytes cell line NCTC-2544.线粒体和p53在补骨脂素加紫外线A诱导人角质形成细胞系NCTC - 2544凋亡中的核心作用。
Toxicol Appl Pharmacol. 2008 Feb 15;227(1):84-96. doi: 10.1016/j.taap.2007.10.004. Epub 2007 Oct 11.
5
Simple copper salt-catalyzed N-arylation of nitrogen-containing heterocycles with aryl and heteroaryl halides.简单铜盐催化含氮杂环与芳基卤化物和杂芳基卤化物的N-芳基化反应。
J Org Chem. 2007 Oct 26;72(22):8535-8. doi: 10.1021/jo0712289. Epub 2007 Sep 29.
6
Highly potent triazole-based tubulin polymerization inhibitors.高效的基于三唑的微管蛋白聚合抑制剂。
J Med Chem. 2007 Feb 22;50(4):749-54. doi: 10.1021/jm061142s. Epub 2007 Jan 24.
7
Synthesis and activity of Combretastatin A-4 analogues: 1,2,3-thiadiazoles as potent antitumor agents.柯里拉京 A-4 类似物的合成与活性：1,2,3-噻二唑作为强效抗肿瘤剂
Bioorg Med Chem Lett. 2007 Feb 15;17(4):869-73. doi: 10.1016/j.bmcl.2006.11.060. Epub 2006 Nov 29.
8
Combretastatin CA-4 and combretastatin derivative induce mitotic catastrophe dependent on spindle checkpoint and caspase-3 activation in non-small cell lung cancer cells.康普瑞他汀CA-4和康普瑞他汀衍生物在非小细胞肺癌细胞中诱导依赖纺锤体检查点和半胱天冬酶-3激活的有丝分裂灾难。
Apoptosis. 2007 Jan;12(1):155-66. doi: 10.1007/s10495-006-0491-0.
9
Novel imidazole-based combretastatin A-4 analogues: evaluation of their in vitro antitumor activity and molecular modeling study of their binding to the colchicine site of tubulin.新型基于咪唑的康普瑞他汀A-4类似物：其体外抗肿瘤活性评估及其与微管蛋白秋水仙碱结合位点结合的分子模拟研究
Bioorg Med Chem Lett. 2006 Nov 15;16(22):5757-62. doi: 10.1016/j.bmcl.2006.08.087. Epub 2006 Sep 6.
10
Medicinal chemistry of combretastatin A4: present and future directions.秋水仙素A4的药物化学：现状与未来方向
J Med Chem. 2006 Jun 1;49(11):3033-44. doi: 10.1021/jm0512903.
Zotero 插件